Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
3,515.00
-200.00 (-5.38%)
Nov 20, 2026, 3:30 PM KST
| Market Cap | 81.75B -63.1% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 132,465 |
| Open | 3,715.00 |
| Previous Close | 3,715.00 |
| Day's Range | 3,505.00 - 3,770.00 |
| 52-Week Range | 3,350.00 - 11,520.00 |
| Beta | 0.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |